Feb 4, 2022 4:00:00 PM
Anthony Finbow, CEO of Eagle Genomics, explains how the impending ‘Bio Revolution’, with the microbiome at its foundation, offers ground-breaking solutions and a wealth of opportunity in data science and bioinformatics.
Feb 4, 2022 4:00:00 PM
Anthony Finbow, CEO of Eagle Genomics, explains how the impending ‘Bio Revolution’, with the microbiome at its foundation, offers ground-breaking solutions and a wealth of opportunity in data science and bioinformatics.